Log in
NYSE:AZN

AstraZeneca Dividend Yield, History & Payout Ratio

$52.78
-0.61 (-1.14 %)
(As of 12/3/2020 12:00 AM ET)
Add
Compare
Today's Range
$52.25
Now: $52.78
$52.96
50-Day Range
$50.16
MA: $53.59
$58.02
52-Week Range
$36.15
Now: $52.78
$64.94
Volume7.89 million shs
Average Volume5.32 million shs
Market Capitalization$138.53 billion
P/E Ratio63.59
Dividend Yield1.65%
Beta0.5

Dividends

AstraZeneca (NYSE:AZN) Dividend Information

AstraZeneca pays an annual dividend of $0.88 per share, with a dividend yield of 1.67%. AZN's most recent semi annually dividend payment was made to shareholders of record on Monday, September 14. AstraZeneca pays out 50.29% of its earnings out as a dividend.
AZN Most Recent Dividend9/14/2020
AZN Annual Dividend$0.88
AZN Dividend Yield1.67%
AZN Three Year Dividend Growth0.00%
AZN Payout Ratio50.29% (Trailing 12 Months of Earnings)
43.35% (Based on This Year's Estimates)
34.38% (Based on Next Year's Estimates)
29.21% (Based on Cash Flow)
AZN Dividend FrequencySemi Annually Dividend
AZN Most Recent Decrease$0.50 decrease on 7/31/2020

Dividend Payments by Month (or Quarter)


AstraZeneca (NYSE:AZN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/31/2020semi-annual$0.452.5%8/13/20208/14/20209/14/2020
2/18/2020semi-annual$0.952.8%2/27/20202/28/20203/30/2020
2/15/2019semiannual$0.954.64%2/28/20193/1/20193/27/2019
7/27/2018semiannual$0.452.35%8/9/20188/10/20189/10/2018
2/5/2018semiannual$0.955.62%2/15/20182/16/20183/19/2018
7/28/2017None$0.442.98%8/9/20178/11/20179/11/2017
2/3/2017semiannual$0.956.81%2/15/20172/17/20173/20/2017
7/29/2016$0.448/10/20168/12/20169/12/2016
2/5/2016$0.932/17/20162/19/20163/21/2016
2/10/2015semiannual$1.905.57%2/18/20152/20/20153/23/2015
8/1/2014semiannual$0.902.48%8/13/20148/15/20149/15/2014
2/10/2014special$1.902.79%2/19/20142/21/20143/24/2014
8/2/2013semiannual$0.903.52%8/14/20138/16/20139/16/2013
2/1/2013special$1.903.72%2/13/20132/15/20133/18/2013
(Data available from 1/1/2013 forward)
This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.